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Executive Summary
Every year, the UK spends £21 billion1 in the creation of new knowledge – via the science system in universities,
research institutes and companies. This investment forms part of an estimated £600 billion, which is spent by OECD
countries around the world, involving some 3 million researchers. Not surprisingly, every country asks the same
questions – what are we getting out of this investment? And is it enough?
To shed some light on the current situation in the UK, this report provides a census of the UK’s science and technology
system. It draws on publicly available data to review the performance of the UK science and technology system, both
in terms of the investments made in the system and the outputs it delivers. Inevitably the census provides a partial
picture of the UK’s science base. The available data covers some of the activities being undertaken, but by no means
all of them. Even with this caveat, the data that are available – particularly when viewed in terms of long-term trends
– offer some interesting insights into the relative performance of the UK. Key among these insights are:
■ The UK has been under-investing in research and development relative to comparator countries for over 20 years,
both in terms of total and per capita R&D investment. Business and government are the two R&D investing sectors
largely responsible for this under-investment.
■ The UK remains one of the leading countries in terms of scientific production. However, the UK’s performance
varies significantly across academic disciplines. The UK performs outstandingly in most biology and bio-medical
related fields, but its performance in chemistry, engineering and physics is relatively weak.
■ In chemistry and physics, the UK’s share of world publications has decreased over the period 1996-2003, and it
is ranked below many comparator countries2 in terms of the relative citation index. In engineering the UK also
shows a decreasing share of world publications over the period 1996-2003, and it is the third lowest in terms of
relative citation index (above only Japan and Finland amongst our set of comparator countries).
■ The UK has under-performed throughout the 1980s and 1990s – relative to the comparator countries – in terms
of patenting, both per capita and per unit of investment (i.e. business expenditures on R&D). The UK’s
underperformance is particularly marked relative to Germany, Japan and several small, high-tech countries.
■ Finally, the UK remains comparatively well connected to the international science and technology system, as shown
by the share of R&D investment and patenting activities conducted abroad by UK companies, and the high
proportion of R&D investment in the UK by non-UK owned companies.
These findings have several implications for the UK, in terms of the performance of the science and technology system.
■ While the UK has traditionally been one of the world’s leading countries in terms of the generation of scientific
knowledge, it is questionable whether this position can be sustained given the long-term trends with regard to 
R&D investment and scientific performance.
■ This question of sustainability becomes even more significant in light of the emergence of new centres of
knowledge creation – i.e. referred to as the newcomer countries in this study. One could view these ‘newcomer
countries’ as new competitors in terms of the production of scientific and technological knowledge.
■ However, scientific competition may not be the right way to think about the challenge posed by the newcomer
countries. If we adopt the perspective of an open science and innovation system, the emergence of new centres
of knowledge production should be seen as an opportunity for scientific collaboration. In this sense, the challenge
for the UK is how to ensure it can engage in the global knowledge production process and develop the countries
capacity to absorb relevant knowledge.
1 Figures from the Office of National Statistics.
2 The comparator countries used in this study include: [1] the traditional comparators – France, Germany, Japan and the United States; 
[2] the small, high-tech countries – Denmark, Finland, Sweden and Switzerland; and [3] the newcomer countries – Brazil, China, India, Singapore, South Korea and Taiwan.
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■ Policy should therefore focus more on how to equip the UK science base to engage in the global knowledge
production process and how to enable UK plc to capitalise on globally produced knowledge. This requires particular
attention to policies that:
– facilitate knowledge networks, cross-country collaborations and the flows of talent from abroad;
– support the supply of well trained scientists in a variety of fields, ensuring that UK retains the necessary
absorptive capacity to be well connected to globally produced science and technology.
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Every year, the UK spends £21 billion3 in the creation of new knowledge – via the science system in universities,
research institutes and companies. This investment forms part of an estimated £600 billion which is spent by OECD
countries around the world, involving some 3 million researchers. Not surprisingly, every country asks the same
questions – what are we getting out of this investment? And is it enough?
Recent evidence suggests that the UK is good at producing scientific knowledge. It is ranked second only to the US in
terms of academic citations, for example, with an impressive 12.2% world share.4 The UK also ranks fifth in the world
for PhDs produced per unit HERD (Higher Education R&D Spend) – the US is ranked eleventh.5
But do we apply the knowledge as effectively as we create it? Here the news is mixed. Anecdotal evidence suggests
that the UK is good at invention, but poor at innovation – the commercial exploitation of new ideas. Famous examples
include the body scanner developed by EMI, and pioneering work on the world’s first computer at the British war time
code breaking centre Bletchley Park – both of which drew on the UK’s science base, but were commercialised
elsewhere. But negative stories such as these ignore innovation success stories in areas like pharmaceuticals and
aerospace.
The fact is that the UK’s innovation from knowledge (IfK) system does work. The question is: can it work better? 
And can it do so at a time when the innovation model is changing? Today, knowledge is created on a truly international
stage. Even major R&D players such as Procter & Gamble now talk of sourcing half or more of their innovations from
outside the company. These changes will have a profound impact on IfK systems. Innovation is increasingly about
managing flows of knowledge across complex – and often global – networks.6
The aim of this report is to provide a census of where the UK’s IfK system stands in light of publically available data.
Ongoing research will supplement these data with new data that will be incorporated into subsequent science base
census publications to take account of global developments – for example the rise of China and India as economic
powerhouses. At this stage, however, we are concerned with mapping out the UK’s current position and considering
the implications of this for the policy and practitioner communities.
Our aim in publishing this census is to draw together data to stimulate debate about the appropriate ways of
conceptualising and enhancing the UK’s IfK system. For ultimately the challenge is to make UK plc more competitive
by creating more innovation from knowledge.
1 Introduction
3 Figures from the Office of National Statistics.
4 Department of Trade and Industry: Office of Science and Technology ‘PSA Target Metrics for the UK research base’, December 2005.
5 Department of Trade and Industry: Office of Science and Technology ‘PSA Target Metrics for the UK research base’, December 2005.
6 It is important to note that IfK – Innovation from Knowledge – does not assume a linear flow from knowledge creation to innovation. 
It is widely recognised that what matters is the exchange of knowledge – innovation influences the creation of new knowledge and vice-versa.
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7The objective of this report is to examine how the UK is positioned in terms of science and technology performance
compared to other countries. This section focuses on the description of the indicators used to conduct the
cross-country comparison, complemented with a brief discussion of the strengths and weaknesses of the indicators
used, and a description of the data sources employed.
Before addressing the main focus of this section, however, it is important to briefly discuss three issues that help 
to understand the background to the indicators used, in particular, and to this report, more generally. These issues refer
to: a) why a country focus?; b) why yet another science and technology report?; and c) does the report implicitly
support the linear model of innovation? Let us first discuss these three issues briefly, since they form the background
for the overall report.
In an increasingly globalised scenario: why a country-level focus?
While open research and innovation has led to an increasingly internationalised scientific and innovation system, there
is no such thing as a ‘free lunch’ for innovative firms or countries. Countries need to sustain and nurture their science
and technology bases, partly to enable the country to connect to the scientific and technological advances occurring
elsewhere, and partly because a healthy science based makes the country an attractive place for international players
to be located.
In brief, the advances in scientific understanding and technological know-how are unforeseeable, and knowledge
spillovers are unlikely to occur in a context of underinvestment, since knowledge can only be absorbed, applied and
transmitted by educated minds. For these reasons, countries seek to retain and nurture their science and technology
bases in order to encourage competitiveness and increase wealth.
Therefore, we think it justified to take the country-level as a unit of analysis, and to examine what are the strengths
and weaknesses of the UK’s science and technology system compared to other countries.
Do we yet need another science and technology report?
All major international organisations, such as the EU and the OECD, periodically produce an exhaustive account on
how countries stand in terms of their science and technology indicators.7 In addition to this, most countries produce
their own periodical reviews on this matter (e.g. OST in the UK; NSF in the US). The intention of this report is neither
to duplicate the information provided elsewhere nor to introduce novel indicators that have yet to be contemplated in
the existing literature. Rather, the objective of this report is to use the extensive data collected mainly by the EU, NSF,
OECD and OST to provide a distinct picture on how the UK stands internationally. Therefore, while the present report
necessary overlaps with existing studies in the use of available data, it goes beyond existing reports in a number of
respects. First, by taking a UK focus, the report looks specifically at how the UK stands when compared to three different
blocks of countries: major industrialised countries – France, Germany, US and Japan –; small, high-tech countries –
Denmark, Finland, Sweden and Switzerland –; and newcomer countries – Brazil, China, India, Singapore, South Korea
and Taiwan. Second, the report examines the long-term trends in the UK by exploring a range of indicators. We argue
that an accurate assessment about how well UK is doing in terms of science and technology performance, and how
well it can be expected to perform in the future, can only be achieved by identifying the long term trends for the
country (relative to comparator countries) along a range of indicators, rather than via snapshots of recent performance.
Finally, in addition to the prior two points, the report examines the UK’s performance across a range of scientific
disciplines, in order to get a balanced picture regarding the areas of strengths and weaknesses of the country.
2 The Science and Technology Performance Framework
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7 OECD (2003) and EC-RSTI (2003), among others.
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Is this report implicitly supporting the linear model?
In developing this report we have received valuable comments and questions from many colleagues. One recurring
theme is the question of whether this report assumes a linear model of innovation. For years the dominant paradigm
was that innovation flowed from scientific progress. Indeed many policy documents still seem to cling to this notion.
However, in the latter decades of the 20th Century, the linear model was challenged both by the science and the
policy communities. In essence their argument was that the pathways from scientific to technological advance are not
uniform, that advances in technology often inspire science, and that many technological developments and innovations
have very little, if any, direct reliance on science (Rosenberg, 1991; Stokes,1997).
Whilst we would concur with these arguments, for the sake of analytical clarity, we have chosen to present the data in
this report using a framework that distinguishes between investment in knowledge; scientific performance; and
technological performance. Although analytically cleaner this framework clearly oversimplifies reality and hence at
various points in the text we will refer to the more complex issues of innovation and knowledge flows.
Indicators used, cautions required, and sources of data
In line with the comments made above, this sub-section describes the indicators used in the report, the sources from
which the data have been drawn, and the strengths and weaknesses of these indicators.
The indicators used in this report address the three main areas of a science and technology system: investment in
knowledge; scientific performance; and technological performance. Section 3 examines the UK’s investment in
knowledge (relative to comparator countries), making use of the standard statistics of research and development
(R&D) expenditures, both overall and broken down by sector of performance of R&D (i.e. business, government and
higher education). Section 4 examines the UK’s performance in producing knowledge by using indicators based 
on scientific publications and citations, both at the country level and disaggregated by scientific discipline. Finally,
section 5 of the report examines the UK’s innovative capacity by looking at patent records.
Section 3 examines and compares the expenditures on R&D in the UK and the three blocks of comparator countries,
focusing on trends in R&D expenditures since the early 1980s. As an overall measure of R&D investment, we use the
‘gross domestic expenditure on R&D’ (GERD), which is the total intramural8 expenditure on R&D performed on the
national territory during a given period. GERD includes R&D performed within a country, including R&D funded from
abroad, but excludes payments for R&D performed abroad.9 The main source for data on R&D expenditures is OECD
– Main Science and Technology Indicators.10
GERD is constructed by adding together the intramural expenditures of four sectors: business enterprise, government,
private non-profit and higher education. Since the private non-profit sector contributes only marginally, as an R&D
performing sector, to GERD (less than 5% of total GERD in most countries), we are not explicitly considering this sector
in this study. Therefore, GERD is mainly composed of BERD (Business Expenditure on R&D), GOVERD (Government
Expenditure on R&D) and HERD (Higher Education Expenditure on R&D).
Business expenditures on R&D (BERD) refer to the total amount of R&D performed in the business enterprise sector,
which includes all firms, organisations and institutions whose primary activity is the market production of goods and
services for sale to the general public. This includes public and private enterprises, and non-profit institutions such as
research institutes, hospitals or chambers of commerce (see OECD (2002)).11
8 Intramural expenditures are all expenditures for R&D performed within a statistical unit (i.e. entity for which the required statistics are compiled) or sector of the economy 
during a specific period, whatever the sources of funds. These comprises labour costs of R&D personnel and purchases of materials, supplies and equipment to support 
R&D performed by the statistical unit in a given year. In contrast, the extramural R&D expenditures are the sums a unit or sector reports having paid to another unit or
sector for the performance of R&D during a specific period (see OECD (2002)).
9 OECD (2002). Frascati Manual: Proposed standard practice for surveys on research and experimental development. OECD, Paris.
10 Main Science and Technology Indicators, MSTI – OECD (various years) www.oecd.org
11 Any private enterprises, public enterprises, or non-profit institutions producing higher education services should be included in the higher education sector.
9Government expenditures on R&D (GOVERD) refer to the total amount of R&D performed by all bodies, departments
and establishments of government that engage in a wide range of activities such as: administration, defence and
regulation of public order, health, education (with the exception of those administered by the higher education sector),
cultural and recreational services, etc.
Higher education expenditures on R&D (HERD) refer to the total amount of R&D performed by all universities, colleges
of technology and other institutions of postsecondary education, whatever their source of finance or legal status. 
Although OECD member countries commit important resources in setting up surveys based on the Frascati Manual 
(OECD (2002)) for collecting data on R&D expenditures, a number of pitfalls remain in regard to internationally
comparable R&D input data. Two limitations are of particular importance. First, the lack of systematic data as a consequence
of countries not reporting timely data (or reporting data that is not comparable), which is particularly noticeable in the case
of R&D personnel data. Second, the OECD’s methodological framework for classifying R&D activities in scientific
subdisciplines is not sufficiently detailed, which makes combining input data on R&D from OECD and publication data 
at disciplinary levels extremely problematic, and the outcomes at best only indicative (Luwel, 2004).
Finally, in section 3 we use both R&D intensity (this is R&D expenditures as a proportion of GDP) and R&D
expenditures (at constant prices) per capita. This is largely done to take advantage of the complementary information
that each indicator provides. While R&D intensity is a useful measure to indicate how much countries invest in R&D in
relation to the value of their total production, and facilitates the comparison of countries of different sizes, this indicator
may lead to a distorted picture caused by the different rate of growth of GDP across countries. For this reason, we
complement that indicator with R&D expenditures per capita.
It is also important to acknowledge that both indicators may differ across countries as a consequence of a different
industrial structure, for instance, as a consequence of a different composition of R&D intensive industries in the
business sector, OECD (2005) and NESTA (2006). However, Griffith and Harrison (2004) found that, when comparing
manufacturing sectors, most of the difference in R&D intensity between UK and major industrialised countries is
accounted by differences within industries (as opposed to shifts in the composition of industries).
Section 4 examines and compares the production of scientific publications as an indicator of a country’s scientific
activity (i.e. the country’s share of world publications and the growth of that share). Since the number of publications
per se does not revel much about quality or usefulness, citations are used as an indicator of the usefulness and
importance of publications. Finally, because there are wide differences across disciplines in terms of publication and
citation patterns, most country comparisons are conducted within scientific disciplines.
The data on publications and citations used in this research come from the NSF (2006) Science and Engineering
Indicators.12 The NSF counts all science and engineering articles, notes and reviews (excluding letters to the editor, news
pieces, and editorials) published in the scientific and technical journals tracked by Thompson ISI in the Science Citation
Index (SCI) and the Social Science Citation Index (SSCI). Articles are attributed to countries by the author’s institutional
affiliation at the time of the publication. The counting of articles and citations is based on the fractional count method,
where the credit for an article with authors from more than one institution is divided among the collaborating
institutions based on the proportion of their participating institutions.
Designations of scientific fields for articles are determined by the classification of the journal in which an article appears.
The scientific fields have been grouped in 12 broad categories by NSF (2006). This report explores seven of these:
clinical medicine, biomedical research, biology, physics, chemistry, engineering and technology, and social sciences.
These seven fields represent 87% of total publications in all fields considered by NSF (2006) in 2003.13
AIM Research – Science and Technology in the UK
12 www.nsf.gov/statistics/seindo6
13 The original list of 12 discipline fields is as follows: clinical medicine, biomedical research, biology, physics, health sciences, chemistry, earth and space sciences, 
engineering and technology, mathematics, social sciences, psychology and professional fields.
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Section 5 examines and compares the UK’s innovative capacity by looking at patent records in the UK and the three
blocks of comparator countries, focusing on trends in patenting since the early 1980s.
The creation and use of technological knowledge are key drivers of an economy’s international competitiveness due
to their impact on improving product quality and process efficiency. Patent records are a codified measure of
a country’s capacity to generate technological knowledge since they capture an outcome of technologically oriented
inventive activity, and therefore patents have been extensively used to measure technological performance.
However, some cautions with the use of patents are in order. On the one hand, not all innovative activities result in a
patent, since in many sectors patenting is not the preferred mechanism to protect inventions from being copied by
competitors. For instance, most innovation and inventions in the service sector are not captured by patents. On the
other hand, not all patents are exploited economically – patents do not measure innovation per se, but rather the
existence of knowledge which has the potential for innovation – and even when they are economically exploited only
a very small proportion of patents leads to a successful innovation in the marketplace.
Notwithstanding all these cautions, patents have traditionally represented an important source of data to measure
technological performance, and allow us to trace technology dynamics in detail and over long time periods (RSTI,
2003).
Following OECD (2003) methodological notes, patent counts are presented here according to the country(ies) of
residence of the inventor(s), thus giving a measure of technological innovativeness of researchers and laboratories
located in a country (as opposed to assigning the patent to the country of residence of the applicant, which could be
a holding organisation whose location might differ from that where the research has been actually conducted).
Finally, three sets of patent indicators are analysed here: patents granted by the US Patent and Trademark Office
(USPTO), triadic patents (i.e. the set of patented inventions for which protection has been sought at all three major
patent offices: the European Patent Office, the USPTO, and the Japanese Patent Office), and patents applied for at the
European Patent Office (EPO). The advantage of triadic patents is that they can eliminate the ‘home bias’ effect (i.e.
US inventors may have a dominance in the US patent system because it is their home market). Triadic patents may
also be associated with patents of a higher expected commercial value, since it is costly to file through three patent
systems (however, it is also likely that they tend to reflect the patenting activity of larger companies who seek, and can
afford, broader international protection) (RSTI, 2003).
The overall picture
We first examine the extent to which there are significant differences in terms of the levels of investment in research
and development (R&D) across countries. As an overall measure of R&D investment, we use the ‘gross domestic
expenditure on R&D’ (GERD).14
As Figure 1 shows, we observe that there are significant differences in terms of inputs invested in R&D between the UK
and its major industrial competitors. In the twenty years to 2003, the UK has invested, on average, 2% of annual GDP
on R&D. This compares with the 2.6% for the US and the 2.8% for Japan. Even more striking, the UK investment as a
proportion of GDP has fallen over this 20-year period, from 2.2% in 1983 to 1.9% in 2003, while the US has remained
stable in its commitments to R&D (from 2.6% in 1983 to 2.7% in 2003) and Japan has increased its investment (from
2.3% to 3.2%, over the same period). Given these trends it is difficult to see how the UK can conform either to the
UK’s Government target of 2.5% of GDP by 201415, or the European Union target of 3% by 2010.
Figure 1: GERD as a percentage of GDP – UK versus major comparators
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In short, the gap between the UK and its four major competitors has grown in terms of R&D investment to GDP. 
That picture does not change much when we compare the UK with a group of high-tech, small countries – Denmark,
Finland, Sweden and Switzerland. As shown in Figure 2, while the four countries considered had similar or lower levels
of GERD per GDP to the UK in the early 1980s, all four countries have experienced a significant growth in their
investments in GERD. By 2003 they were between 0.7 (compared to Denmark) and 2.1 (compared to Sweden)
percentage points higher that the UK.
14 When using R&D expenditures, absolute values are expressed in real terms from data on Purchasing Power Parities at 2000 prices and exchange rates. (see MSTI (OECD)).
15 HM Treasury, DTI, DfES (2004). Science & innovation investment framework 2004-2014. London, July.
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Figure 3: GERD as a percentage of GDP – UK versus newcomer countries
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Figure 2: GERD as a % of GDP – UK versus small, high-tech countries
In the case of the newcomer countries, GERD to GDP ratios are only available for China, Singapore and South Korea.
The investments made by both Singapore and South Korea have been steadily increasing. In the case of South Korea,
GERD to GDP was similar to the UK’s in the early 1990s, but the ratio for South Korea was 2.6% by 2003. 
Singapore caught up with the UK by 1998 and jumped ahead of the UK in 2000, a position that it has maintained.
China’s investment is still below the UK’s, but the gap between the two countries has been progressively reduced.
China’s GERD per GDP was 29% of the UK figure in 1995, and 60% of the UK level by 2003 (see Figure 3).
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Breakdown by R&D performing sector
The data already presented illustrate the UK’s GERD as a % of GDP is not only lower than most of its comparator countries,
but has also declined relative to them. Why is this the case? By examining in more detail the three main constituent
elements to the gross expenditures on R&D, we gain a better understanding on the relative efforts on R&D expenditures.
Figures 4, 5 and 6 show the UK’s investment in BERD, GOVERD and HERD respectively, both in terms of percentage to
GDP and in terms of the absolute level of investment relative to country population. From these figures it can be deduced
that the primary areas of concern, underlying the UK’s under-investment in R&D, are BERD and GOVERD components.
Figure 4a: Business Expenditures on R&D to GDP – UK versus major comparators
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As shown in Figure 4a, UK business expenditures on R&D relative to GDP have been decreasing (reaching a level
of 1.2% by 2003), while the investments made by its major comparator countries have been increasing (in 2003
Germany was 0.5 percentage points above the UK, while the US was 0.6 percentage points above the UK, 
and Japan 1.12).
These differences are not a result of higher GDP growth rates in the UK relative to comparator countries, but a
consequence of a lower volume of investment in research and development (relative to country size). When we look
at the absolute levels of investment per capita (at constant prices), the annual growth rate in BERD per capita between
1981 and 2003 was 1.5% for the UK, while the US had an annual growth rate of 2.7% and Japan had an annual
growth rate of 4.5%.
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Figure 4b: Business Expenditure on R&D per capita (in US$2000, PPP adjusted) – UK versus major comparators
A similar story unfolds when looking at the small, high-tech countries. Since 1997, BERD as a percentage of GDP has
been increasingly higher for the four high-tech countries compared to the UK figures. By 2003, the R&D intensity of
the business sector ranged from 0.5 percentage points higher (in the case of Denmark), to 1.7 percentage points
higher (in the case of Sweden). Moreover, the annual growth rate of BERD per capita (in constant prices) has been
higher than 5% for almost all these countries (with the exception of Switzerland) for the period 1991-2003.
When examining the figures of BERD as a percentage of GDP in emerging economies, the picture is mixed. 
South Korea is above the UK’s levels (having reached a 2% of GDP by 2003, 0.8 percentage points above the UK);
Singapore has overtaken the UK’s levels (since 2001 Singapore’s business has invested 1.3% of GDP in R&D, and 
is moving ahead of the UK); while China has been steadily catching up. China has increased its BERD to GDP from 
a 0.3% in 1991 (1.1 percentage points below the UK) to a 0.7% in 2003 (0.5 percentage points below the UK).
UK GOVERD also displays a decreasing trend over the same time period. By 2003 UK was the country with the lowest
percentage of GOVERD to GDP (0.18%). This compares to 0.33% for the US and 0.43% for France. Moreover, 
in contrast with BERD, in the case of GOVERD, there is also a decreasing trend in terms of volume of investment 
per capita over the whole period 1981-2003 (see Figures 5a and 5b).
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Figure 5a: Government Expenditure on R&D to GDP – UK versus major comparators
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Figure 5b: Government Expenditures on R&D per capita (in US$2000, PPP adjusted) 
– UK versus major comparators
In Higher Education Expenditures, UK has followed a pattern of investment similar to that of major competitors, both
in term of investment to GDP and investment per capita. It is worth noting that, regarding HERD per capita, UK has the
second highest annual growth rate over the period 1981-2003, only behind the US (3.5% and 4.3%, respectively)
(Figures 6a and 6b).
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Figure 6a: Higher Education Expenditure on R&D – UK versus major comparators
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Figure 6b: Higher education expenditure on R&D per capita (in US$2000, PPP adjusted)
– UK versus major comparators
However, the UK figures on R&D performed in the UK higher education are less in line with those of the small,
high-tech countries. Since the early 1990s, all these four countries are well above UK figures on R&D intensity in the
higher education sector (see Figure 6c). By 2003, Denmark was 0.2 percentage points above the UK, Finland and
Switzerland 0.3 percentage points above, and Sweden 0.5 percentage points above.
Regarding the emerging economies, only Singapore displays HERD to GDP figures above the UK levels (i.e. 0.56% in
2003), while both China and South Korea are below UK (with figures of HERD to GDP of 0.12% and 0.27%
respectively). However, over the period 1995-2003, these three emerging economies have observed an average
annual growth rate in their HERD to GDP of 6.5%, compared to the 0.7% of the UK.
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Figure 6c: Higher education expenditure on R&D – UK versus small, high-tech countries
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Source: OECD Main Science and Technology Indicators
Internationalisation of Business R&D
In a context of increasing internationalisation of R&D investment flows by multinational enterprises, a country’s
competitiveness largely relies on the capacity to retain access to centres of science and technological excellence and
to become an attractive place to perform R&D activities. Several reports have argued that the UK is well placed to gain
from an increase in international flows of R&D, since UK is an attractive place for foreign owned firms to conduct R&D
activities and it is a major investor in R&D overseas (see DTI, 2005).
Indeed, most industrialised countries have experienced a continuous increase in the proportion of business R&D
performed by affiliates of foreign companies, and this trend has been particularly strong in the case of UK. For instance,
the proportion of business R&D performed by affiliates of foreign companies increased from 14% to 23% for France
between 1994 and 2003, from 16% to 25% in the case of Germany between 1993 and 2001, from 14% to 34%
between 1993 and 2002 for Sweden, and from 28% to 45% between 1994 and 2003 for the UK (see OECD (2005)).16
However, the comparative high proportion of business R&D performed by affiliates of foreign companies in the case
of the UK, might be driven by the low overall level of BERD reported above. To gain a better understanding of the role
played by UK in the international flows of business R&D, it is helpful to look at the US profile of international R&D flows,
examining the foreign owned R&D in the US and the US owned R&D overseas. We observe that the position of UK
is very strong, though Germany stands in a very similar position than the UK.
Figure 7a shows the R&D performed abroad by majority-owned foreign affiliates of US parent companies over the
period 1994-2002 by country (in percentages) (NSF, 2006). While Figure 7b shows the R&D expenditures by majority
owned affiliates of foreign companies in the US (period 1987-2002) by country (in percentages) (NSF, 2006). 
Both figures show that both the UK and Germany are the major investors of R&D in the US and the major recipients
of R&D investment from the US. In short, while the UK has a comparative low level of domestic business R&D relative
to major competitors, the UK has a much more active role in terms of international flows of business R&D, both in
terms of its role as an investor overseas and in terms of its capacity to attract business R&D from abroad.
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Figure 7a: R&D performed abroad by majority-owned foreign affiliates of US parent companies, 
by country – 1994-2002
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Note: Newcomers include Brazil, China (with Hong Kong), India, South Korea, Singapore and Taiwan
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Figure 7b: R&D expenditures by majority-owned affiliates of foreign companies in US, 
by country – 1987-2002
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The overall picture
While the previous section focused on how much money countries are investing in R&D (i.e. the input data), this
section addresses one of the performance indicators of a country’s R&D system: scientific performance. This will be
examined mainly through the patterns of scientific publications displayed by UK and our comparator countries, both
overall and within scientific fields.
As mentioned in section 2, this research considers the production of scientific publications as an indicator of a country’s
scientific activity (i.e. the country’s share of world publications and the growth of that share), and the number of
citations as an indicator of the usefulness and importance of publications. Moreover, due to the existence of wide
differences across disciplines in terms of publication and citation patterns, most country comparisons will be conducted
within scientific disciplines.
The UK scientific research base has long been considered at the highest level in the world ranking, second only to the
US on the majority of scientific indicators (HM Treasury, 2005).17 As shown in Tables 1 and 2, the UK is responsible for
seven percent of world scientific publications and eight percent of world scientific citations (NSF, 2006).
However, in recent years significant challenges have emerged for the UK. On the one hand, Japan has overtaken the
UK to become the world’s second most prolific publisher and Germany is getting closer to UK’s world share of
publications. Moreover, regarding world share of citations, the UK has maintained the second position, but Japan and
Germany have significantly reduced the gap with the UK.
On the other hand, the emergence of newcomer countries has had an impact on the scientific production causing a
shift in the composition of major players in the world landscape of scientific producers (Zhou and Leydesdorff, 2006).
As Table 1 shows, a number of newcomer countries have entered the list of the 20 most prolific publishers, such as:
China, South Korea, Taiwan and Brazil. Moreover, increasing numbers of scientific producers may be one of the driving
forces underlying the sharp fall of US world shares both in terms of volume of publications and citations.
Table 1: Ranking of countries by world publication shares
Source: NSF (2006) Science and Engineering Indicators
Countries World Share 1988 Countries World Share 2003
1 United States 38.09 1 United States 30.23
2 United Kingdom 7.83 2 Japan 8.60
3 Japan 7.38 3 United Kingdom 6.91
4 USSR 6.78 4 Germany 6.34
5 Germany 6.28 5 France 4.58
6 France 4.59 6 China 4.18
7 Canada 4.59 7 Canada 3.55
8 Italy 2.41 8 Italy 3.53
9 Australia 2.12 9 Spain 2.41
10 India 1.90 10 Australia 2.26
11 Netherlands 1.84 11 Russia 2.26
12 Sweden 1.62 12 South Korea 1.97
13 Spain 1.16 13 Netherlands 1.93
14 Switzerland 1.14 14 India 1.83
15 Israel 1.05 15 Sweden 1.47
16 China 0.99 16 Taiwan 1.33
17 Poland 0.86 17 Brazil 1.24
18 Belgium 0.77 18 Switzerland 1.22
19 Denmark 0.74 19 Israel 0.99
20 Finland 0.60 20 Poland 0.97
17 HM Treasury, DTI, DfES (2005). The ten-year Science & Innovation Investment Framework. Annual Report 2005. July 2005.
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Table 2: Ranking of countries by world citations
Source: NSF (2006) Science and Engineering Indicators
Finally, the UK is the leading country among the G8 in terms of number of publications per capita (HM Treasury, 2005).
As shown in Figure 8, the UK is well ahead in terms of publications per million capita relative to Germany, France and
Japan (Figure 8 shows the publications per million capita of each comparator country relative to UK figures over two
periods of time). Moreover, none of the major competitor countries is reducing the gap with the UK on this science
productivity indicator.
Figure 8: Papers per head of population
Countries World Share 1992 Countries World Share 2003
1 United States 51.75 1 United States 42.39
2 United Kingdom 8.27 2 United Kingdom 8.10
3 Japan 6.50 3 Japan 7.34
4 Germany 5.86 4 Germany 7.04
5 France 4.34 5 France 4.65
6 Australia 4.16 6 Australia 3.72
7 Netherlands 2.14 7 Italy 3.01
8 Italy 2.04 8 Netherlands 2.29
9 Canada 1.86 9 Canada 2.11
10 Sweden 1.82 10 Spain 1.90
11 Switzerland 1.62 11 Switzerland 1.71
12 USSR 1.16 12 Sweden 1.65
13 Spain 0.83 13 China 1.51
14 Israel 0.79 14 South Korea 0.94
15 Belgium 0.77 15 Belgium 0.90
16 Denmark 0.76 16 Israel 0.89
17 Finland 0.55 17 Denmark 0.88
18 India 0.54 18 Finland 0.80
19 Austria 0.41 19 Russia 0.74
20 Norway 0.38 20 India 0.73
Source: Source: NSF (2006) Science and Engineering Indicators
However, it is important to note that when considering a wider range of countries, the small, high-tech countries have
higher productivity ratios than the UK, as shown in Table 3.
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Table 3: Number of publications per million capita
Source: NSF (2006) Science and Engineering Indicators
The breakdown by scientific discipline
While the UK performs well in most scientific disciplines, some research fields do better than others. In order to highlight
distinctive trends across scientific fields, this section focuses on the UK performance, both in volume of publications and
citations, across a range of research areas: Bio-medical related research (including biology, clinical medicine and
biomedical research), physics, engineering and social sciences. 
To examine and compare countries’ scientific productivity it is helpful to normalise scientific output by the number of
people involved in research within each field. However, comparable data on R&D personnel or total researchers across
scientific fields within countries are not available.18 For this reason we have chosen a different way of comparing the
publication profiles of our comparator countries.
We have proceeded through a three-stage analysis. First, we describe the country’s relative degree of specialisation 
in each field, by comparing the shares of each country’s total publications in each scientific discipline. This provides 
a rough approximation to the scientific strengths and weaknesses of each country.
Second, we compare our set of countries in terms of their publication shares in 2003 and the annual growth of the publication
shares for the period 1996-2003, within each scientific discipline.19 Countries differ widely in terms of their volume of
publications (i.e. shares of world publications): what this analysis should be helpful for is in order to identify relevant trends.
For instance, to identify which larger publishing countries are proving more resilient in the face of competition from countries
with smaller publication shares; and which smaller publishing countries (as measured by world publication shares) appear as
more active in terms of challenging the position of the traditional, most prolific publishing countries.
Countries 1990-92 Countries 2001-2003
1 Sweden 951 1 Sweden 1135
2 Switzerland 904 2 Switzerland 1107
3 Canada 831 3 Finland 972
4 United States 768 4 Denmark 931
5 Denmark 752 5 Netherlands 797
6 United Kingdom 705 6 United Kingdom 794
7 Netherlands 693 7 Australia 765
8 Finland 646 8 Canada 744
9 Australia 630 9 New Zealand 735
10 New Zealand 624 10 Norway 713
11 Norway 585 11 United States 703
12 Belgium 423 12 Iceland 660
13 Germany 418 13 Belgium 598
14 France 414 14 Austria 571
15 Iceland 385 15 Germany 525
16 Austria 365 16 France 507
17 Japan 329 17 Japan 451
18 Czech Republic 294 18 Ireland 431
19 Ireland 261 19 Italy 398
20 Italy 248 20 Spain 397
18 Even at the country level, countries such as the US do not publish data on total R&D personnel in compliance with OECD standards, and for other countries the series 
are highly discontinuous.
19 We consider the years 1996 and 2003 in our analysis as they are the only two years for which the NSF (2006) Science and Engineering Indicators provides information 
on international publications broken down by discipline.
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20 The Index equals 1 if the country’s share of cited literature equals its world share of scientific literature in a given discipline. Note that the country’s citation of own literature 
is excluded, and that citations are computed on fractional-count basis. In drawing comparisons over time, we consider the years 1995 and 2003 since these are the two years
for which information on the relative citation index is presented broken down by discipline.
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Finally, in order to more comprehensively assess the scientific performance of the UK, it is important to consider the
scientific impact of publications. The scientific impact is generally captured by citations. To do this we have collected
data from the NSF (2006), using the ‘relative citation index’. This index measures the relative prominence of scientific
production on the basis of the share of cited literature adjusted for its share of published literature.20
Biomedical related fields: Publications shares and citations
UK has a comparatively large proportion of publications in life science disciplines:
Clinical medicine, biomedical research and biology account together for about 53% of all UK publications in 2003.
This is a similar proportion to the US (54%) and slightly larger than that of Germany, France and Japan (50%, 47%
and 47% respectively). For the small, high-tech countries, the publications on biomedical-related fields account for, 
on average, 60% of their publications, while for the new emerging economies that percentage is significantly lower,
35% (see Figure 9).
Figure 9: Proportion of publications in the biomedical-related field by country in 2003
The UK has an outstanding position in terms of its world publication share in each of these three fields of life sciences.
As Figure 10, 11 and 12 show, the UK was the third most prolific publishing country in 2003, only behind the US and
Japan, in all these three disciplines, with a market share of 8% in clinical medicine, 7.2% in biomedical research and
6% in biology. However, in all three cases the UK is the largest publishing country that has experienced the most acute
decrease in its biomedical world publication share over the period 1996-2003 (the only exception being biomedical
research, where France has seen a larger decrease of its world publication share than the UK). The UK has experienced
a negative annual average growth of its world publication share of 2.2% in clinical medicine, 1.8% in biomedical
research and 3% in biology. This compares to a negative annual growth for the other four major comparator countries
of, on average, 0.5%, 0.8% and 1% in each of the three disciplines respectively (see Figures 10, 11 and 12).
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Figure 10: Publication share and growth of share in % (1996-2003) – Clinical Medicine
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Figure 11: Publication share and growth of share in % (1996-2003) – Biomedical Research
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Figure 12: Publication share and growth of share in % (1996-2003) – Biology
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The small, high-tech countries, which are relatively specialised in the life science disciplines, have world publication
shares within the range of 1-2% in all these disciplines. Regarding growth of world publication shares, the picture is
mixed: while all four countries are experiencing a contraction of their world publication shares in clinical medicine,
Denmark and Finland display positive growth trends in biology and biomedical research, while Sweden has a negative
growth rate in all three disciplines. 
As expected, the larger growth rates in world publication shares correspond to the emerging economies. China has
been outstanding on this respect, getting very close to France world publication share in both biology and biomedical
research. For instance, while by 1996 China’s world publication share in biology was 20% of France’s world publication
share, by 2003 China’s world publication share is 65% of France’s. However, other emerging countries, such as India,
have experienced a much more modest growth trend in the life sciences (particularly for India, world publication share
growth rates have been comparatively low in the cases of biology and biomedical research). 
As Figures 13, 14, 15a and 15b show, UK performs well in terms of the relative citation index in the life sciences
compared to major competitors (particularly relative to Japan), and is generally in line with the performance of the
small, high-tech countries. Relative to the emerging economies, the UK is well above all emerging economies in terms
of the relative citation index in all three scientific fields, suggesting that while the UK is losing ground in terms of world
publication share the impact of UK publications is still relatively high.
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Figure 13: Relative Citation Index – Biology
Source: NSF (2006) Science and Engineering Indicators
Figure 14: Relative Citation Index – Clinical Medicine
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Figure 15a: Relative Citation Index – Biomedical Research
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Physics and chemistry: publication shares and citations 
The UK has a comparatively low proportion of its total publications in physics and chemistry. In 2003, physics accounted
for 9.3% of all UK publications, and chemistry for 8.2%. While these are similar proportions to those of the US (8.8% and
7.5%, respectively), they are substantially lower than those of Germany, France and Japan (the averages for these three
countries are 18.2% for physics, and 13.3% for chemistry). For the small, high-tech countries, physics and chemistry
publications account for, on average, 10.8% in physics and 8.9% in chemistry. The emerging economies show a distinct
pattern to that of the UK and the small, high-tech countries, with 19.6% of their publications in physics, 
and 18% of their publications in chemistry (see Figures 15a, 15b and 16).
Figure 15b: Proportion of publications in physics by country
Source: NSF (2006) Science and Engineering Indicators
27AIM Research – Science and Technology in the UK
US
Japan
Germany
China
France
UK
South Korea
India
Taiwan
Brazil
Switzerland
Sweden
Singapore
Finland
Denmark
-5 5 10 15 20 250
19.1
12.9
7.7
7.5
4.6
5.6
-3.0
3.2
11.3
2.4
0.1
1.6
4.1
1.5
6.7
1.3
-2.8
1.1
-1.5
0.6
0.5
0.5
16.4
2.1
-2.2
11.3
-0.8
-2.1
0.8
-2.3
Publication share 2003 Average growth of share 1996-2003
Figure 16: Proportion of publications in chemistry by country
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The UK has a comparatively low ranking in terms of world publication shares in both physics and chemistry. By 2003
the UK was the 6th most prolific publishing country in these two fields of science, behind China, France, Germany,
Japan and US. In both scientific fields, UK has dropped in the rankings in terms of world publication shares between
1996 and 2003: one position down in physics (from a world publication share of 5.7% to 4.6%), and two positions
down in chemistry (from a world publication share of 6.2% to 4.8%).
Figure 17: Publication share and growth of share in % (1996-2003) – Physics
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Once again, the larger growth rates in world publication shares correspond to the emerging economies. China has been
outstanding jumping to the 4th largest most prolific country in publications in physics and the 3rd largest in chemistry.
China has shifted from a world publication share of 3.2% in 1996, to a world publication share of 8.7% in 2003 in
chemistry, overtaking France, Germany and the UK (and a similar pattern regarding physics). In general, our set of
emerging economies have experienced a fast increase in their world publication shares, with the exception of India,
for which the increase in its world publication share has been comparatively moderate.
Regarding the prominence of the scientific production in these two fields, as measured by the relative citation index,
the assessment of the UK’s international position is mixed. Even though UK maintains its international position over
the period 1995-2003 in relation to the relative citation index in physics, it is clear that even on that account the UK
is not performing outstandingly well in these two disciplines.
US
Japan
China
Germany
France
UK
India
South Korea
Taiwan
Brazil
Switzerland
Sweden
Singapore
Finland
Denmark
-6 6 12 18 240
19.1 
10.6
8.7
6.6
4.8
5.0
4.1
1.7
2.7
9.3
1.5
4.2
1.3
11.6
1.3
0.1
1.0
-0.8
0.5
0.5
12.6
0.4
0.6
1.4
-3.7
-3.7
-2.2
15.6
-0.4
-1.4
Publication share 2003 Average growth of share 1996-2003
The UK has been, among the major comparators, the country with the largest negative growth rate in world publication
share: -3% and -3.7% for physics and chemistry, respectively, over the period 1996-2003 (with Germany showing the
same negative growth rate in chemistry as the UK). This compares to a negative annual growth for the other four major
comparator countries of, on average, 1.1% in physics and 1.9% in chemistry (see Figures 17 and 18).
The small, high-tech countries have market shares within the range of 0.4% and 1.3% in these two disciplines. 
In physics, all four countries with the exception of Finland show decreasing growth rates in their world publication shares;
while in chemistry, all four show positive growth rates in world publication shares with the exception of Sweden.
Figure 18: Publication share and growth of share in % (1996-2003) – Chemistry
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On the one hand, when all world countries are considered, the UK is ranked only tenth in both physics and chemistry,
and UK moves down three positions in the ranking over the period 1995-2003 within chemistry (see Appendix Table
5-62, NSF (2006)). On the other hand, many comparator countries are catching up or moving ahead of the UK. 
As shown in Figure 19, with only the exception of Japan, all other industrialised economies in our comparator group
are either at the same level or above the UK in terms of the prominence of the scientific papers in the field of physics.
The situation is better in chemistry, where the UK has a relative citation index above that of Germany, France, Japan
and Finland, though below that of the US, Sweden, Switzerland and Denmark (Figure 20).
Relative to the emerging economies, UK is well above in terms of the relative citation index in both disciplines, though
it is important to highlight that Singapore, and to a lesser extent Taiwan, have reduced the distance with the UK. 
For instance, within physics, Singapore’s index was 31% of the UK’s index in 1995, and 73% in 2003; while the figures
for Taiwan were 40% of the UK’s in 1995, and 54% of the UK’s in 2003. In chemistry, while the catching up from our
set of countries has been less remarkable than in physics, Singapore’s relative citation index was by 2003 only 20%
below that of the UK (from a level 28% lower than the UK’s in 1995).
Figure 19: Relative Citation Index – Physics
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Figure 20: Relative Citation Index – Chemistry
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Engineering: Share of publications and citations
The UK has a comparatively low proportion of its total publications in engineering, a discipline where most East Asian
emerging economies seem to be comparatively specialised. In 2003, engineering accounted for 7.1% of all UK
publications. This is a similar proportion to the proportion of engineering in most western economies in our set 
(e.g. 8.9% for the average of the major industrial comparator countries, and 6.4% for the average of the four small,
high-tech economies, in 2003). By contrast, the emerging economies show a distinct pattern, where on average
engineering accounts for 18% of total publications (see Figure 21).
Figure 21: Proportion of publications in engineering, by country
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Figure 22: Publication share and growth of share in % (1996-2003) – Engineering
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The UK was the 4th most prolific publishing country in engineering in 2003, behind the US, Japan, and China. 
The UK has dropped one position in the rankings in terms of world publication shares between 1996 and 2003:
from a world publication share of 7% to 5.5%. Among the group of major industrial comparator countries, the UK
and US are the two countries with the largest decreases in world publication share: a negative growth rate above
3.5%. This compares to a negative growth rate of 0.1% for Japan, and an average positive growth rate of 0.2% for
France and Germany (see Figure 22).
The small, high-tech countries have world publication shares within the range of 0.4% and 1.2% in engineering. 
With the exception of Sweden, all four countries have experienced increasing growth rates in their world publication
shares in this discipline (an average growth rate of 0.9% over the period 1996-2003).
Once again, the larger growth rates in world publication shares correspond to the emerging economies. Brazil, China
and South Korea have been particularly outstanding, with average growth rates of world publication shares of 12% or
above. China has moved from the 6th to the 3rd position in terms of world publication share in engineering, moving
up from a market share of 3.5% in 1996, to a world publication share of 7.8% in 2003, overtaking France, Germany
and the UK. In general, our set of emerging economies has experienced a fast increase in their world publication
shares, with the exception of India (with a negative growth over this period) and Taiwan, with a comparatively lower
growth rate of 1.4%.
Regarding the relative citation index, UK’s international position has suffered an important blow in the ranking within
the field of engineering, from the 10th position in 1995 to the 18th position in 2003. This shift downwards in the UK’s
ranking is reflected in the comparison with our set of comparator countries. As shown in Figure 23, with the exception
of Japan and Finland, all other industrialised countries display higher values of the relative citation index in 2003. 
In addition to this, Singapore, South Korea, and China have dramatically reduced the distance with respect to UK values,
as shown in Figure 24.
Figure 23: Relative Citation Index – UK versus industrialised countries – Engineering
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Figure 24: Relative Citation Index – UK versus Newcomer countries – Engineering
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Social Sciences: publications per capita and citations
The UK has the highest proportion of a country’s total publications in the field of social sciences (compared to our set
of comparator countries): 6.1% in 2003. This compares to an average of 2.2% for the other four major industrial
competitors, 2.5% for the small, high-tech countries, and 1.5% for the emerging economies. This clearly signals a UK
comparative specialisation in the field of social science (see Figure 25).
Figure 25: Proportion of publications in Social Sciences by country
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The UK was the 2nd most prolific publishing country in Social Sciences in 2003, only behind the US, with a world
publication share of 13.6%. In contrast with the US, the UK has experienced an increase of its world publication share
over the period 1996-2003 (i.e. a growth rate of 0.25%, versus a negative growth rate of -1.5% for the US). 
This scientific field shows a much more skewed distribution of publications, where the 3rd most prolific country 
– i.e. Germany – had a market share of 3.9% in 2003 (see Figure 26). 
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The small, high-tech countries have world publication shares within the range of 0.6% and 1.2% in Social Sciences.
On average, all four countries have experienced high growth rates in their world publication shares in this discipline
(average growth rates of 5.7% over the period 1996-2003). Indeed, the small, high-tech countries have had growth
rates in their world publication shares that compare with those of the emerging countries, which on average have
experienced a growth rate of 4.8%. In this case, Singapore and South Korea are the two emerging economies with the
highest growth rates of world publication shares: 11.9% and 9.7%, respectively (see Figure 26). 
Figure 26: Publication share and growth rate of share in % (1996-03) – Social Sciences
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However, regarding the relative citation index the UK is not performing that well. Both the US and almost all the small,
high-tech countries have a higher prominence in their scientific literature in this field. This indicates that while the UK
is doing extremely well in terms of volume of publications, the UK’s performance is below that of several industrialised
comparator countries in terms of citations, within the field of Social Sciences (see Figure 27).
Figure 27: Relative Citation Index – Social Sciences
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Figures 29: Trends of publication outputs – UK versus small, high-tech countries
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Discussion on scientific performance
The first thing to highlight regarding scientific performance is that most countries have been increasing the absolute
number of publications over the last fifteen years. Indeed, the world number of publications, as collected by the NSF
(2006), has expanded from 466,419 in 1988 to almost 698,726 in 2003, at an annual growth rate of 2.8%. 
Such a positive growth trend has been present in our set of comparator countries. As shown in the figures below, all
the countries considered in this study have experienced an expansion in its volume of scientific publications. The issue
then is not a question of whether our set of countries has experienced a positive growth in their scientific production
but a question of how much. It is clear that the pace at which different countries have expanded their scientific
production dramatically differs across groups of countries, and between the countries in each group. Indeed, while on
average our set of major industrial competitors (i.e. UK, US, Germany, France and Japan) has an average annual growth
rate of publications of 2.5% over the period 1988-2003, the growth rate for the small, high-tech countries has been
3.1%, and the one for the group of newcomer countries has been 12.6% (see Figures 28, 29 and 30).
Figures 28: Trends of publication outputs – UK versus major industrial competitors
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Figure 30: Trends of publication outputs – UK versus Newcomer countries21
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21 While the average annual growth rate of 12.6% for emerging economies includes India, this country has not been included in Figure 30 since its growth rate, while higher than
the UK’s, is well below the average of the other newcomer countries, and in a Figure like 30 would largely overlap with the UK trend giving a misleading signal that its growth 
is undifferentiated from that of the UK’s.
The large increase in publication output from the emerging economies has lead, as mentioned in Table 1, to a situation
in which several newcomers appear listed among the 20 largest publishing countries. Looking at the trends in more
detail, we observe that not only China has raised to an outstanding 6th position in terms of world publication shares
in 2003, but also that the evolution of its publication share points to a convergence with the UK in the medium term.
Moreover, if all newcomer countries are considered together, they have already reached the second largest world share
in 2003, only behind the US, with about 11% of world publications (see Figure 31), and have overtaken the UK’s
figures since 1999. In addition to this, while China plays an important role in the overall growth of the newcomer
countries, China’s contribution to the newcomer shares represent less than 40%: the remaining 60% is largely evenly
distributed across the other 5 countries that form our group of newcomer countries.
Figure 31: Trends of publications’ world market shares – UK versus Newcomer countries
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Figure 33: Number of publications per HERD (US$2000, PPP adjusted)
As the figures overleaf express, the emerging economies are becoming outstanding centres of scientific production
within the world scientific landscape, pointing towards a shift in the centre of gravity of the world system of science.
This clearly poses a challenge to the traditional nodes of scientific production, since the emerging countries are
disputing the world publication market shares of incumbent countries in the scientific production scene. The other side
of the coin is that the emerging economies provide a great opportunity for incumbent countries to draw upon the
new knowledge generated by the emerging centres of knowledge production.
Since one of the consequences that the emerging countries have had on the world system of science is to put an
increasing pressure on the traditional advantages of world leading countries, it is likely that this may have had an
impact on the relationship between the number of publications and R&D investment. That seems to be happening,
in particular for the case of the US. The US has experienced a substantial drop in the number of publications per unit
of investment in R&D, both when measured in terms of total R&D performed by Government and higher education
together, and by higher education alone (see Figures 32 and 33). The ratio measures the number of publications at
a point in time relative to the weighted average investment in R&D over the previous three years.
Figure 32: Number of publications per GOVERD+HERD (US$2000, PPP adjusted)
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While the UK is well above other major industrial competitors in terms of the ratio of publications per unit of investment
performed in the public sector, the UK seems to have been also at strain regarding this indicator, particularly since 2000
onwards. It is interesting to note that neither Germany, France or Japan display a decreasing trend over the whole
period. Also, most small, high-tech countries follow a pattern similar to that of the UK, both in terms of overall values
of the ratio and in terms of its trend (Figure 34). The only two countries that have experienced a substantial growing
trend in the ratio of publications to public R&D investment are South Korea and Switzerland – in this latter case, since
1993 onwards – (and to a lesser extent China) (Figure 35).22
Figure 34: Number of publications to GOVERD+HERD (US$2000, PPP adjusted)
22 We cannot assess the ratios of publications per unit of investment for the other newcomer countries because we do not have comparable data from OECD regarding 
R&D investments.
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Figure 35: Number of publications per GOVERD+HERD (US$2000, PPP adjusted)
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The overall picture
In order to assess the technological performance we examine patenting records for our set of countries over the period
1981-2003. We first look at country rankings according to world shares of triadic patents. As Table 4 shows, the ten
largest countries remain largely unaltered over time. While three emerging countries appear listed among the 20 largest
in terms of world patent shares by 2001, as opposed to the case of world publications shares, none of them are still
among the ten largest countries.
Table 4: World shares of triadic patents (%)
Source: MSTI, OECD (2005)
While UK is ranked 5th in terms of its (triadic) patent world shares, when patent figures are normalised by country 
size, the UK ranking drops dramatically below the 10th position in the world ranking of triadic patents per capita 
(see Table 5).
Examining in more detail the long-term trends of triadic patents per capita, it becomes clear that the UK has been
performing worse than our set of comparator countries. Compared to the major industrial competitors, since the early
1990s the UK has been growing at a lower pace that the comparator countries (with the exception of France), and
thus, Germany, the US and Japan are moving further apart from UK records of patenting per capita (see Figure 36).
Countries 1995 Countries 2001
1 US 35.0 1 US 34.9
2 Japan 27.0 2 Japan 24.9
3 Germany 13.7 3 Germany 15.8
4 France 5.4 4 France 5.2
5 UK 4.3 5 UK 4.6
6 Switzerland 2.1 6 Netherlands 2.1
7 Netherlands 2.1 7 Switzerland 1.8
8 Sweden 2.0 8 Italy 1.8
9 Italy 1.7 9 Sweden 1.7
10 Canada 1.1 10 Canada 1.4
11 Belgium 1.1 11 Finland 1.1
12 South Korea 0.9 12 South Korea 1.1
13 Finland 0.9 13 Belgium 0.9
14 Australia 0.6 14 Australia 0.8
15 Austria 0.6 15 Austria 0.6
16 Denmark 0.5 16 Denmark 0.5
17 Spain 0.3 17 China 0.3
18 Norway 0.3 18 Spain 0.3
19 Ireland 0.1 19 Norway 0.2
20 Hungary 0.1 20 Singapore 0.2
5 Technological Performance
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Table 5: Triadic patents per million capita
Source: MSTI, OECD (2005)
Figure 36: Triadic patents per million capita – UK versus major competitors
Countries 1995 Countries 2001
1 Switzerland 105.5 1 Switzerland 118.2
2 Sweden 79.3 2 Finland 98.5
3 Japan 75.3 3 Japan 92.3
4 Finland 61.1 4 Sweden 91.8
5 Germany 59.0 5 Germany 90.7
6 Netherlands 46.8 6 Netherlands 61.9
7 United States 46.7 7 United States 57.7
8 Belgium 36.8 8 Belgium 42.1
9 Denmark 36.2 9 Denmark 41.4
10 France 32.8 10 France 40.3
11 Austria 27.3 11 United Kingdom 36.7
12 United Kingdom 25.9 12 Austria 34.9
13 Iceland 22.5 13 Norway 23.9
14 Norway 18.4 14 Iceland 21.1
15 Canada 12.8 15 Canada 20.6
16 Australia 12.5 16 Singapore 20.3
17 Italy 10.7 17 Ireland 19.2
18 Ireland 8.6 18 Australia 19.2
19 South Korea 7.3 19 Italy 14.8
20 Singapore 6.8 20 South Korea 10.6
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When compared with the small, high-tech countries, the UK is even further below and with little signs of convergence.
Particularly, Sweden and Finland have experienced much higher growth rates since 1991 (an annual growth rate of
6.7 and 12.7% for Sweden and Finland, respectively, relative to 4.2% for the UK) (see Figure 37).
Finally, regarding the newcomer countries the picture is mixed, largely caused by the different country scales. 
Regarding triadic patenting records, we could only get information for China, South Korea and Singapore (OECD (2006)).
While China’s figures of patenting records per capita are still very low relative to international standards, 
South Korea and Singapore have been clearly catching up with major industrialised countries, such as the UK
(see Figure 38), though still remain clearly low.
Figure 38: Triadic patents per capita – UK versus South Korea and Singapore
AIM Research – Science and Technology in the UK
Figure 37: Triadic patents per capita – UK versus small, high-tech countries
A similar picture emerges when we look at the patents granted by the USPTO. To avoid problems of home-biased, 
we have not included data corresponding to the US in the figures. As Figures 39, 40 and 41 show, the UK is well below
major industrial competitors and small, high-tech countries, and both South Korea and Singapore have overtaken 
UK figures since 1998 onwards.
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Figure 39: USPTO granted patents – UK versus major competitors
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Figure 40: USPTO granted patents – UK versus small, high-tech countries
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Figure 41: USPTO granted patents – UK versus South Korea and Singapore
23 Business R&D (BERD) measured in million PPP at 2000 prices, and calculated using a three-year time lag between year of R&D expenditures and year of patenting. 
In addition, we have computed a three year weighted average for BERD, using a weighting score structure of 0.25/0.5/0.25. 
Finally, similarly as we did with the publications and public R&D investment, we have compared in this case the country
patenting records (i.e. triadic patents) to business performed R&D investments.23 As Figures 42 and 43 show, the UK
is well below most of the small, high-tech countries (with the exception of Sweden, and more recently, Denmark), and
well below Japan and Germany, and since the early 1990s the UK has followed a very similar pattern to that of the
US and France. When compared to the newcomer countries, the UK is still well ahead of Singapore and South Korea
in terms of patenting per unit of business performed R&D (i.e. in 2002, South Korea had a ratio of triadic patents 
per BERD that was 46% of UK’s ratio, while Singapore was 63% of UK’s ratio). 
Figure 42: Triadic patents per unit of BERD – UK versus major competitors
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Figure 43: Triadic patents per unit of BERD – UK versus small, high-tech countries
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Finally, the UK does seem to perform much better than comparator countries when looking at the technology produced
abroad by its own multinationals, indicating a rather strong globalisation of their R&D activities. 
Figure 44 shows the percentages of EPO patents owned by a country (i.e. by its companies or other major patenting
institutions) that are invented abroad by affiliates of its own multinationals (source RSTI, 2003), in 1999. The UK has
more than a third of their patents invented by their multinationals’ affiliates abroad. Only Sweden has a similar
proportion, among our set of comparator countries (no data is available here for Switzerland or the newcomer
countries). While the US, Germany and Japan have comparatively lower percentages of patents produced by their
overseas affiliates. 
It is important to add that all these countries have more than 90% of the patents produced by their overseas affiliates
either in Europe or the US, and thus, the extent of the globalisation of patenting remains highly concentrated in mainly
these two economic blocks. However, with this caution in mind, Figure 44 shows that UK’s companies have a much
more stronger internationalisation of its technological activities (as measured by overseas affiliate patenting).
Figure 44: Patents produced by a country’s foreign-based affiliates (%) – 1999
Source: Third Report on S&T Indicators, RSTI (2003)
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This section summarises the various figures that we have presented throughout this report. To explore the aggregate
trends we have reviewed these data in terms of each country’s position and growth for a range of indicators. By position
we refer to the country’s level within a given indicator (e.g. GERD per capita) in 2003, compared to the comparator
group average. By growth we refer to the country’s annual growth rate within a given indicator compared to the
comparator group average growth rate. Annual growth rates have been calculated over time periods that differ across
indicators, as a consequence of the lack of comparable information across indicators. We have prioritised to compute
growth rates for time periods longer than 5 years, in order to get a more reliable indicator of trends. So, for instance,
while annual growth rates for GERD to GDP refer to the period 1981-2003, the annual growth rate for the relative
citation index covers the period 1995-2003. While the time periods to compute growth rates differ across indicators,
they are consistently the same across countries within each indicator.
Tables 6 and 7 show the relative position and growth of each country for each indicator, where colours code the cells:
■ Green indicating that the country is ‘moving ahead’: the country is both above the comparator group average 
in terms of level and growth rate.
■ Blue indicating that the country is ‘catching up’: the country is currently below the comparator group average 
but experiencing a higher than average growth rate.
■ Yellow indicating that the country is ‘losing momentum’: the country is currently above the comparator group
average but experiencing a lower than average growth rate.
■ Red indicating that the country is ‘falling behind’: the country is both below the comparator group average in terms
of level and growth rate.
Tables A, B and C in the Appendix provide the raw data on each country’s position and growth across a range of
indicators, which form the basis for the colours used in Tables 6 and 7.
As Tables 6 and 7 show, UK is within the ‘falling behind’ territory both regarding investment in R&D and technology
performance. With the exception of higher education expenditures in R&D, the UK has been clearly under-investing in
R&D compared to both the major comparator countries and the overall set of comparator countries. Among the major
comparator countries, the US remains well positioned in terms of R&D investments levels, showing comparatively
higher growth rates in almost all R&D investment indicators (with the only exception of GOVERD to GDP).
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Regarding indicators on technology, the UK shows a poor performance not only when compared to major comparator
countries, but also relative to our whole set of comparator countries. Germany and Japan are performing particularly
well on technology-related indicators, while South Korea and Singapore are the countries with the largest growth rates
in terms of (triadic) patents per unit of business performed R&D.
Regarding scientific performance, while the UK does very well in terms of overall number of publications per capita,
this is likely to be a consequence of the UK’s comparatively high level of specialisation in biomedical-related fields,
where the UK does particularly well in terms of world publication market shares. However, in disciplines such as
chemistry, engineering and physics, the UK is performing poorly, showing a decreasing trend in its world publication
shares in these three disciplines.
Table 6: Overall performance – UK versus major comparator countries
Investment in R&D
GERD to GDP
GERD per capita
BERD to GDP
BERD per capita
GOVERD to GDP
GOVERD per capita
HERD to GDP
HERD per capita
Scientific Performance
Publications per capita
Publ. share: Engineering
Publ. share: Physics
Publ. share: Chemistry
Publ. share: Biomedical Research
Publ. share: Social Sciences
Citations per paper
R. Citation Index: Engineering
R. Citation Index: Physics
R. Citation Index: Chemistry
R. Citation Index: Biomedical Res.
R. Citation Index: Social Sciences
Publications per HERD
Publicatiosn per PUBERD
Technology Performance
Triadic patents per capita
USPTO per capita
EPO per capita
Patents (triadic) per BERD
UK US Germany France Japan
Regarding scientific impact, the UK performs relatively well overall. However, UK is falling behind in engineering
compared to the major comparator countries, and the UK’s relative citation index tends to be lower than average when
compared with the small, high-tech countries across a wide range of disciplines such as: chemistry, engineering,
physics and social sciences.
Finally, it is noticeable that the newcomer countries are not only playing an increasingly important role in terms of the
volume of publications in all disciplines, but also they are catching up in terms of the impact of their publications, 
as shown by the predominance of blue regarding the relative citation index across disciplines.
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Table 7: Overall performance – UK versus all comparator countries
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7 Implications for Policy, Practice and Research
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The data presented in this report raise some significant questions about the likelihood of the UK sustaining its
traditionally held position as one of the world’s leading generators of scientific knowledge. Two specific issues underpin
this concern. First, the data show that the UK has systematically under-invested in science and technology relatively to
its comparator countries for over 20 years. Second, the rapid emergence of new centres of knowledge production
poses some potentially significant challenges for the UK, as well as for other developed economies.
UK science and technology policy is often framed in terms of UK Plc – how do we make interventions to enable the
UK to become more productive and competitive as a nation. Innovation research and industrial practice suggest that
the innovation process is changing. Increasingly executives are discussing open innovation, with major R&D players,
such as Procter & Gamble, now talking of sourcing half or more of their innovations from outside the company.
Executives in firms recognise that no single firm can hope to have a monopoly on knowledge production in any specific
field. Hence the challenge for firms – in an era of open innovation – is how to sustain their own ability to innovate,
whilst simultaneously developing their capability to access and absorb relevant innovations made by others.
These twin capabilities – in house innovation coupled with the appropriation of externally produced knowledge – raise
some important challenges, not least how should these activities be resourced and how should firms balance their
effort between them. If the firm devotes too much resource to looking outside, searching for the innovations of others,
there is a danger that the firm’s own capacity to innovate is likely to atrophy and over time it will lose its ability 
to understand and absorb the innovations of others. Of course the counter argument also applies. If the firm is too
internally focused it will miss those important innovations made by others.
Should we apply the same thinking to science and technology policy? Instead of worrying solely about the output of
the UK’s science and technology base, perhaps we should also worry about how to enhance the country’s capability
to engage in the global knowledge production process. For it is by engaging in the global knowledge production
process that the UK will be able to access and absorb scientific developments made elsewhere that might be of value.
In policy terms, this dual focus – on the UK’s scientific capability and the extent to which the UK’s scientific community
engages in the global knowledge production process – requires a shift in policy emphasis.
It can be argued that UK policy is currently too US-centric, with the result that developments in the small, high-tech
and newcomer countries might be missed. In the research community too much emphasis is placed on the US model
of research, with numerous disciplines seeking to conform to the US norms, rather than arguing the case for a pluralist
definition of good research. Striking the right balance between different models of research is clearly complex, but
ignoring the strength of some of the European research traditions is naive. The issue for the UK and particularly for
those who influence research in the country is how to strike an appropriate balance and focus in light of the country’s
investments in science and technology.
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An emerging research agenda
In addition to important policy questions, the data presented in the census raise some significant topics for future
research. First there is the question of why the small, high-tech countries perform so well across the board. The data
suggest that Denmark, Finland, Sweden and Switzerland all achieve outstanding levels of performance in terms of
publication per capita and triadic patents per capita. Why do these countries achieve such high levels of performance?
A second question relates to the UK’s outstanding performance in bio-medical fields. What is it about the UK’s scientific
community that allows the country to perform so well in terms of bio-medical research? To what extent does the 
UK’s traditionally strong position in pharmaceuticals influence the country’s performance? If this were the sole
explanatory variable then one could argue that the UK would also perform well in engineering. Yet the data suggest
that the UK is losing its status in engineering research – which, of course, raises another question.
A third question concerns the propensity of UK scientists to engage with global knowledge production – especially
centres of knowledge production outside the US. Given the rapid emergence of the newcomer countries and 
the sustained strength of the small, high-tech countries, the question is to what extent does the UK engage with 
these communities?
And this question of engagement raises a fourth issue – namely the extent of collaboration between the science base
and the industrial community. The dominant model of scientific research is the linear model – namely that investment
in science and technology should result in knowledge that can be commercialised and hence generate economic
value. As discussed at the outset of this census, this linear model is questioned by many. The notion of knowledge
flowing from the science community to the business community is regarded as outdated. Instead the assumption 
is that both communities inform one another. However, to what extent this is this true and, if it is true, what are 
the processes of knowledge exchange (as opposed to knowledge flow) that have a larger impact on innovation, 
are issues that deserve further investigation. It is to these questions that we will turn our attention in the next reports.
51
DTI (2005): Office of Science and Technology ‘PSA Target Metrics for the UK research base’, December 2005.
EC-RSTI (2003): ‘Third European Report on Science & Technology Indicators 2003. Towards a knowledge-based
economy’, EC: Brussels.
Griffith, R. and Harrison, R. (2003): ‘Understanding the UK’s poor technological performance’, IFS Briefing Note no.37.
HM Treasury, DTI and DfES (2004): ‘Science & Innovation Investment Framework 2004-2014’. London, July.
HM Treasury, DTI (2005): ‘R&D intensive businesses in the UK’. DTI Economic Papers No. 11, March 2005.
HM Treasury, DTI and DfES (2005): ‘The ten-year science & innovation investment framework’. Annual Report 2005, July.
Luwel, M. (2004): ‘The use of input data in the performance analysis of R&D systems’, in Moed, H.F. et al. (eds.)
Handbook of quantitative science and technology research, Kluwer Academic Publishers: London.
OECD-MSTI: ‘Main Science and Technology Indicators’ (various years), OECD: Paris. www.oecd.org
OECD (2002): ‘Frascati Manual. Proposed standard practice for surveys on research and experimental
development’, OECD: Paris.
OECD (2003): ‘OECD Science, Technology and Industry Scoreboard’, OECD: Paris.
NESTA (2006): ‘The innovation gap. Why policy needs to reflect the reality of innovation in the UK’, London, October.
NSF (2006): ‘Science and Engineering Indicators’, 2006. www.nsf.gov/statistics/seind06
Rosenberg, N. (1991): ‘Critical issues in science policy research’, Science and Public Policy 18: 335-346.
Stokes, D. (1997): ‘Pasteur’s Quadrant. Basic science and technological innovation’. Brookings Institution Press:
Washington.
Zhou, P. and Leydesdorff, L. (2006): ‘The emergence of China as a leading nation in science’, Research Policy 35: 83-104.
References
AIM Research – Science and Technology in the UK
52 AIM Research – Science and Technology in the UK
Table A: Raw data on position and growth for the UK and the group of major comparator countries
Note: Levels in 2003 are the current values in 2003 (as in the case of scientific performance) or an average for the period 1999-2003 for the figures
on R&D expenditures (both in terms of percentage of GDP and per capita) and patents. The period for which growth rates are calculated vary across
indicators. For all R&D investment indicators and patent indicators, growth rates refer to the period 1981-2003 (except for the newcomer countries,
for which R&D data is available from 1991 or later). For world publication shares, growth rates refer to the period 1996-2003. For the relative citation
index, the growth rates refer to the period 1995-2003. For citations per paper, the growth rates are calculated for the period 1992-2003.
France Germany Japan UK US
Level Growth Level Growth Level Growth Level Growth Level Growth
2003 rate(%) 2003 rate(%) 2003 rate(%) 2003 rate(%) 2003 rate(%)
Investment in R&D
GERD to GDP (%) 2.2 0.7 2.5 0.2 3.1 1.8 1.9 -0.9 2.7 0.7
GERD per capita 569.6 2.4 629.9 1.5 793.5 3.8 486.6 1.4 932.3 2.7
(US$2000, PPP)
BERD to GDP (%) 1.4 0.9 1.7 0.3 2.2 2.5 1.2 -0.8 2.0 0.7
BERD per capita 358.6 2.7 439.6 1.6 579.3 4.5 321.0 1.5 674.1 2.7
(US$2000, PPP)
GOVERD to GDP (%) 0.4 -0.9 0.3 0.1 0.3 0.7 0.2 -4.2 0.3 -1.1
GOVERD per capita 96.9 0.9 85.9 1.4 76.3 2.7 51.6 -1.9 106.6 0.8
(US$2000, PPP)
HERD to GDP (%) 0.4 1.4 0.4 0.2 0.4 0.8 0.4 1.1 0.3 2.2
HERD per capita 106.1 3.1 104.4 1.3 113.2 2.7 102.9 3.5 116.1 4.3
(US$2000, PPP)
Scientific performance
Publications  0.5 2.3 0.5 1.0 0.4 3.6 0.8 1.6 0.7 0.0
per (thousand) capita
World Publication share: 4.4 0.2 5.4 0.2 11.6 -0.1 5.5 -3.6 23.5 -3.9
Engineering (%)
World Publication share: 5.6 -0.8 7.7 -2.1 12.9 0.8 4.6 -3.0 19.1 -2.3
Physics (%)
World Publication share: 5.0 -2.2 6.6 -3.7 10.6 -0.4 4.8 -3.7 19.1 -1.5
Chemistry (%)
World Publication share: 4.8 -2.3 6.3 -0.7 8.3 0.6 7.2 -1.8 36.0 -0.9
Biomedical Research (%)
World Publication share: 2.7 0.8 3.9 1.5 1.4 3.9 13.6 0.2 44.9 -1.5
Social Sciences (%)
Citations per paper 2.1 1.9 2.3 3.1 1.9 1.6 2.4 1.9 3.1 1.9
Relative Citation Index: 0.7 -0.2 0.9 5.3 0.6 0.6 0.7 0.1 0.9 0.6
Engineering
Relative Citation Index: 0.8 0.2 1.0 0.0 0.6 0.5 0.9 0.8 1.1 -0.5
Physics
Relative Citation Index: 0.8 1.9 0.8 2.0 0.6 0.6 0.9 1.4 1.1 -0.1
Chemistry
Relative Citation Index: 0.7 0.7 0.8 1.0 0.6 1.0 0.9 1.0 1.1 -0.2
Biomedical Research
Relative Citation Index: 0.6 7.8 0.4 7.8 0.3 0.8 0.7 3.3 0.8 -0.4
Social Sciences
Publications  5.3 -1.2 5.3 -0.4 4.0 0.2 8.9 -1.7 6.9 -3.5
per (million) HERD
Publications  2.7 1.1 2.9 -0.3 2.4 0.3 5.5 0.2 3.5 -1.2
per (million) PUBERD
Technology performance
Triadic patents  39.7 2.6 83.1 2.9 97.0 5.6 33.2 2.8 59.0 4.3
per (million) capita
USPTO  75.9 3.1 165.2 3.1 303.1 5.7 79.7 3.4 399.5 4.9
per (million) capita
EPO  116.3 4.1 252.8 4.6 145.1 8.0 91.7 3.5 1 01.7 5.6
per (million) capita
Patents (triadic) 0.1 -0.1 0.2 1.6 0.2 1.6 0.1 1.2 0.1 1.3
per (million) BERD
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Table B: Raw data on position and growth for the group of small, high-tech countries
Table C: Raw data on position and growth for the group of newcomer countries
Brazil China India Singapore South Korea Taiwan
Level Growth Level Growth Level Growth Level Growth Level Growth Level Growth
2003 rate(%) 2003 rate(%) 2003 rate(%) 2003 rate(%) 2003 rate(%) 2003 rate(%)
Investment in R&D
GERD to GDP (%) – – 1.0 4.0 – – 2.0 8.0 2.5 3.1 – –
BERD to GDP (%) – – 0.6 8.7 – – 1.3 7.7 1.9 1.9 – –
GOVERD to GDP (%) – – 0.3 -1.2 – – 0.3 10.9 0.3 -2.1 – –
HERD to GDP (%) – – 0.1 6.4 – – 0.5 8.3 0.3 4.8 – –
Scientific performance
Citations per paper 1.2 3.7 1.2 6.2 1.0 6.1 1.4 5.7 1.4 5.8 1.3 3.2
Relative Citation Index:   0.5 2.5 0.5 3.3 0.5 3.4 0.6 8.8 0.6 2.3 0.5 1.5
Engineering
Relative Citation Index: 0.4 -0.1 0.3 4.7 0.4 4.7 0.6 12.0 0.5 2.6 0.5 4.5
Physics
Relative Citation Index: 0.4 -0.2 0.4 1.7 0.4 5.0 0.8 2.8 0.5 4.6 0.5 1.6
Chemistry
Relative Citation Index: 0.2 3.6 0.2 -1.4 0.2 7.8 0.7 2.8 0.4 3.6 0.4 1.5
Biomedical Research 
Relative Citation Index:  0.4 1.9 0.5 5.0 0.3 4.1 0.6 4.6 0.6 0.7 0.5 1.0
Clinical Medicine 
Relative Citation Index: 0.4 2.4 – – – – 0.5 -0.9 0.6 -1.4 0.4 5.0
Biology
Relative Citation Index: 0.4 -0.2 0.4 1.7 0.4 5.0 0.8 2.8 0.5 4.6 0.5 1.6
Social Sciences
Outputs per unit of investment
Patents (triadic) – – 0.002 1.7 – – 0.1 6.4 0.05 9.7 – –
per (million) BERD
Publications – – 6.1 0.5 – – 6.1 0.0 5.6 7.2 – –
per (million) HERD
Denmark Finland Sweden Switzerland
Level Growth Level Growth Level Growth Level Growth
2003 rate(%) 2003 rate(%) 2003 rate(%) 2003 rate(%)
Investment in R&D
GERD to GDP (%) 2.4 4.4 3.4 5.2 3.9 2.7 2.6 0.9
BERD to GDP (%) 1.6 5.9 2.4 6.3 3.0 3.4 1.9 0.9
GOVERD to GDP (%) 0.2 -0.9 0.4 1.4 0.1 0.3 0.0 -6.7
HERD to GDP (%) 0.5 3.3 0.6 4.4 0.8 1.3 0.6 1.9
Scientific performance
Citations per paper 2.6 2.9 2.3 3.1 2.4 1.3 3.0 1.2
Relative Citation Index: Engineering 1.0 -2.7 0.6 1.2 0.8 -0.9 1.2 2.1
Relative Citation Index: Physics 1.3 0.3 0.8 -0.2 0.9 0.5 1.3 -0.3
Relative Citation Index: Chemistry 1.1 0.9 0.7 0.2 1.0 -2.3 1.1 0.3
Relative Citation Index: Biomedical Research 0.8 2.7 0.7 1.3 0.7 0.4 1.2 -0.1
Relative Citation Index: Clinical Medicine 0.8 2.1 0.9 1.6 0.8 0.5 1.0 0.0
Relative Citation Index: Biology 0.9 -0.2 0.8 2.2 1.0 1.1 1.3 2.7
Relative Citation Index: Social Sciences 0.8 -2.2 0.7 1.5 0.9 1.7 1.0 7.3
Outputs per unit of investment
Patents (triadic) per (million) BERD 0.1 -1.4 0.2 7.0 0.1 -0.6 0.2 -1.4
Publications per (million) HERD 7.7 -2.0 6.7 -1.8 5.6 -0.3 6.3 -1.7
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